These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36434734)

  • 1. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
    Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
    J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal profiles of plasma gelsolin, cytokines and antibody expression predict COVID-19 severity and hospitalization outcomes.
    Asare-Werehene M; McGuinty M; Vranjkovic A; Galipeau Y; Cowan J; Cameron B; Cooper CL; Langlois MA; Crawley AM; Tsang BK
    Front Immunol; 2022; 13():1011084. PubMed ID: 36148234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of blood-brain barrier permeability and reduction of tight junction protein expression are modulated by chemokines/cytokines induced by rabies virus infection.
    Chai Q; He WQ; Zhou M; Lu H; Fu ZF
    J Virol; 2014 May; 88(9):4698-710. PubMed ID: 24522913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability.
    Feng S; Zou L; Wang H; He R; Liu K; Zhu H
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Cytokine Responses of APOE3 and APOE4 Blood-brain Barrier Cell Types to SARS-CoV-2 Spike Proteins.
    Chaves JCS; Milton LA; Stewart R; Senapati T; Rantanen LM; Wasielewska JM; Lee S; Hernández D; McInnes L; Quek H; Pébay A; Donnelly PS; White AR; Oikari LE
    J Neuroimmune Pharmacol; 2024 May; 19(1):22. PubMed ID: 38771543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The regulation of tight junction protein via PKCα/β for abnormal permeability of brain microvascular endothelial cells exposed to paraquat].
    Guo MZ; Zhu CD; Cai Q; Xu YL; Huang M
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Dec; 36(12):881-889. PubMed ID: 30812071
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells.
    Choi JY; Park JH; Jo C; Kim KC; Koh YH
    Biochem Biophys Res Commun; 2022 Oct; 626():66-71. PubMed ID: 35970046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells.
    Li J; Ye L; Wang X; Liu J; Wang Y; Zhou Y; Ho W
    J Neuroinflammation; 2012 Jul; 9():161. PubMed ID: 22768975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone.
    Olajide OA; Iwuanyanwu VU; Lepiarz-Raba I; Al-Hindawi AA
    Inflammation; 2021 Oct; 44(5):1865-1877. PubMed ID: 33860869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
    DeOre BJ; Tran KA; Andrews AM; Ramirez SH; Galie PA
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):722-728. PubMed ID: 34687399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes and regulatory mechanism of tight junction proteins in in vitro model of lead-induced blood-brain barrier injury].
    Xu Y; Che H; Liu M; Ke T; Ma Y; Chen J; Hao X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1141-6. PubMed ID: 24200059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 causes dysfunction in human iPSC-derived brain microvascular endothelial cells potentially by modulating the Wnt signaling pathway.
    Yamada S; Hashita T; Yanagida S; Sato H; Yasuhiko Y; Okabe K; Noda T; Nishida M; Matsunaga T; Kanda Y
    Fluids Barriers CNS; 2024 Apr; 21(1):32. PubMed ID: 38584257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 productively infects human brain microvascular endothelial cells.
    Yang RC; Huang K; Zhang HP; Li L; Zhang YF; Tan C; Chen HC; Jin ML; Wang XR
    J Neuroinflammation; 2022 Jun; 19(1):149. PubMed ID: 35705998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; McGary H; Razmpour R; Galie PA; Potula R; Andrews AM; Ramirez SH
    bioRxiv; 2020 Jun; ():. PubMed ID: 32587958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies.
    Eigenmann DE; Xue G; Kim KS; Moses AV; Hamburger M; Oufir M
    Fluids Barriers CNS; 2013 Nov; 10(1):33. PubMed ID: 24262108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability.
    Kovacs-Kasa A; Zaied AA; Leanhart S; Koseoglu M; Sridhar S; Lucas R; Fulton DJ; Vazquez JA; Annex BH
    Microbiol Spectr; 2022 Feb; 10(1):e0167121. PubMed ID: 35171047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise.
    Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y
    Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.
    Rahman M; Irmler M; Keshavan S; Introna M; Beckers J; Palmberg L; Johanson G; Ganguly K; Upadhyay S
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of altered glycaemia on blood-brain barrier endothelium: an in vitro study using the hCMEC/D3 cell line.
    Sajja RK; Prasad S; Cucullo L
    Fluids Barriers CNS; 2014 Apr; 11(1):8. PubMed ID: 24708805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.